Cargando…
Current approaches of nanomedicines in the market and various stage of clinical translation
Compared with traditional drug therapy, nanomedicines exhibit intriguing biological features to increase therapeutic efficiency, reduce toxicity and achieve targeting delivery. This review provides a snapshot of nanomedicines that have been currently launched or in the clinical trials, which manifes...
Autores principales: | Shan, Xiaoting, Gong, Xiang, Li, Jie, Wen, Jingyuan, Li, Yaping, Zhang, Zhiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293719/ https://www.ncbi.nlm.nih.gov/pubmed/35865096 http://dx.doi.org/10.1016/j.apsb.2022.02.025 |
Ejemplares similares
-
Current hurdles to the translation of nanomedicines from bench to the clinic
por: Đorđević, Snežana, et al.
Publicado: (2021) -
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
por: Zhao, Zhiwen, et al.
Publicado: (2023) -
Artificial exosomes for translational nanomedicine
por: Li, Yong-Jiang, et al.
Publicado: (2021) -
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018) -
Challenges in nanomedicine clinical translation
por: Metselaar, Josbert M., et al.
Publicado: (2020)